Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
injectable
Pharma
Foresee eyes rare puberty disease nod for Camcevi with trial win
Foresee's Camcevi, currently approved as a treatment for advanced prostate cancer, showed promise in a central precocious puberty (CPP) phase 3 study.
Zoey Becker
Jan 2, 2026 11:03am
Amphastar lays out plan to quadruple production capacity at HQ
Jul 16, 2025 7:53am
PCI puts $365M-plus into multiple US, EU manufacturing projects
Sep 24, 2024 12:48pm
Roche doubles down with subcutaneous FDA nod for MS star Ocrevus
Sep 13, 2024 1:50pm
Zydus hit with FDA warning letter flagging glass contamination
Sep 11, 2024 11:42am
Merck-Curon, Legend, Amgen—Fierce Pharma Asia
Aug 16, 2024 8:59am
